Primrose Bio launches following merger of Primordial Genetics and Pelican Technology Holdings with $15 million in funding from Ligand Pharmaceuticals SAN DIEGO, Sept. 18, 2023 /PRNewswire/ — Primrose Bio, Inc., a stand-alone private biotechnology company focused on developing…
